Yantai Zhenghai Biotechnology Co., Ltd. (SHE:300653)
18.40
-0.35 (-1.87%)
Apr 21, 2026, 3:04 PM CST
SHE:300653 Revenue
In the year 2025, Yantai Zhenghai Biotechnology had annual revenue of 364.14M CNY with 0.25% growth. Yantai Zhenghai Biotechnology had revenue of 88.42M in the quarter ending December 31, 2025, with 23.02% growth.
Revenue
364.14M
Revenue Growth
+0.25%
P/S Ratio
9.40
Revenue / Employee
927.34K
Employees
400
Market Cap
3.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 364.14M | 913.16K | 0.25% |
| Dec 31, 2024 | 363.23M | -50.43M | -12.19% |
| Dec 31, 2023 | 413.65M | -19.57M | -4.52% |
| Jan 1, 2023 | 433.22M | 33.05M | 8.26% |
| Dec 31, 2021 | 400.18M | 106.89M | 36.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beijing Kawin Technology Share-Holding | 1.15B |
| Guangdong VTR Bio-Tech | 830.87M |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Cabio Biotech (Wuhan) | 574.88M |
| Suzhou Fushilai Pharmaceutical | 439.57M |
| Shanghai Model Organisms Center | 421.26M |
| Jiangsu Sihuan Bioengineering | 344.38M |
| Shanghai Shen Lian Biomedical | 288.27M |